当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 资产负债表

共同药业

(300966)

  

流通市值:10.99亿  总市值:17.68亿
流通股本:7167.47万   总股本:1.15亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金116,793,029.53181,973,811.45138,791,768.46162,821,421.68
应收票据及应收账款218,626,088.17219,701,890.69190,621,341.38236,711,866.55
其中:应收票据6,250,022.239,502,405.1714,119,99830,848,505
应收账款212,376,065.94210,199,485.52176,501,343.38205,863,361.55
应收款项融资9,205,533.6415,694,632.5852,388,708.1154,067,927.51
预付款项28,118,132.6519,796,7375,633,940.134,374,865.04
其他应收款合计2,493,662.882,146,241.552,363,184.992,093,964.42
存货370,732,972.76396,157,512.81442,095,294.27456,057,583.96
其他流动资产26,731,260.3234,259,728.9718,522,783.516,075,312.73
流动资产平衡项目0000
流动资产合计772,701,690.45869,731,565.5850,417,020.84932,202,941.89
非流动资产:
长期股权投资48,121,851.0248,235,950.2847,910,298.2248,010,868.52
投资性房地产18,487,082.2718,644,592.0818,802,101.8918,959,611.7
固定资产203,319,754.02208,991,308.72184,196,756.24190,847,165.62
在建工程1,320,133,111.811,181,676,130.86879,911,849.83690,211,412.01
使用权资产1,091,565.251,208,691.11,350,395.145,392,701.35
无形资产50,716,884.850,995,491.0826,729,197.3526,885,079.12
长期待摊费用11,838,136.9812,651,304.8611,287,036.211,825,832.72
递延所得税资产23,546,956.822,621,685.3822,856,191.9721,634,073.43
其他非流动资产28,622,344.9332,983,979.32171,967,735.27160,422,580.11
非流动资产平衡项目0000
非流动资产合计1,705,877,687.881,578,009,133.681,365,011,562.111,174,189,324.58
资产平衡项目0000
资产总计2,478,579,378.332,447,740,699.182,215,428,582.952,106,392,266.47
流动负债:
短期借款177,163,151.38110,092,522.22130,086,333.33160,128,972.22
应付票据及应付账款501,949,451.78532,236,731.62359,652,355.11259,194,545.83
其中:应付票据124,414,360.5216,813,793.21139,576,519.8327,828,966.82
应付账款377,535,091.28315,422,938.41220,075,835.28231,365,579.01
预收款项496,293.5845,292.31211,266.7352,291.26
合同负债1,142,837.513,468,912.291,672,684.811,848,718.99
应付职工薪酬5,319,755.387,403,890.554,404,814.854,682,231.78
应交税费2,096,409.884,084,373.323,993,084.581,800,830.6
其他应付款合计633,706.461,640,492.531,900,961.611,879,732.45
一年内到期的非流动负债20,334,524.9522,723,181.0517,848,884.8118,084,007.38
其他流动负债2,989,412.094,710,546.899,488,830.9619,484,006.65
流动负债平衡项目0000
流动负债合计712,125,543.01686,405,942.78529,259,216.76467,455,337.16
非流动负债:
长期借款334,115,867.85349,715,867.85315,022,770.11274,017,770.11
应付债券308,900,713.25302,658,126.92296,595,905.97290,636,775.2
租赁负债451,444.51538,628.8287,347.594,574,696.1
预计负债30,002.530,002.5--
递延收益95,500,819.4284,327,123.7969,064,773.0669,278,205.66
递延所得税负债257,296.18289,416.56322,668.211,252,249.85
非流动负债平衡项目0000
非流动负债合计739,256,143.71737,559,166.44681,093,464.94639,759,696.92
负债平衡项目0000
负债合计1,451,381,686.721,423,965,109.221,210,352,681.71,107,215,034.08
所有者权益(或股东权益):
实收资本(或股本)115,278,902115,278,902115,277,518115,277,446
其他权益工具96,493,567.4496,493,567.4496,503,315.896,503,832.95
资本公积411,303,748.06410,774,731.48411,471,670.26410,397,592.57
盈余公积9,861,298.499,861,298.499,861,298.499,861,298.49
未分配利润323,888,332.79320,341,025.75320,122,860.48314,810,417.16
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计956,825,848.78952,749,525.16953,236,663.03946,850,587.17
少数股东权益70,371,842.8371,026,064.851,839,238.2252,326,645.22
股东权益平衡项目0000
股东权益合计1,027,197,691.611,023,775,589.961,005,075,901.25999,177,232.39
负债和股东权益合计2,478,579,378.332,447,740,699.182,215,428,582.952,106,392,266.47
公告日期2024-04-262024-04-262023-10-252023-08-29
审计意见(境内)标准无保留意见
TOP↑